PHLPP2 and non-small cell lung carcinoma: Meanwhile, the result showed that low PHLPP2 expression was one of the key factor leading to poor OS in NSCLC patients, the pathological staging (pTNM) staging and PHLPP2 expression were independent prognostic factors for OS (77).